{"created":"2023-06-19T11:40:57.197355+00:00","id":1205,"links":{},"metadata":{"_buckets":{"deposit":"a84dd7f2-b41f-4205-af4f-a1ecb96dfda4"},"_deposit":{"created_by":14,"id":"1205","owners":[14],"pid":{"revision_id":0,"type":"depid","value":"1205"},"status":"published"},"_oai":{"id":"oai:setsunan.repo.nii.ac.jp:00001205","sets":["196:197"]},"author_link":["2081","2079","2078","2080"],"item_10007_contributor_5":{"attribute_name":"研究分担者","attribute_value_mlt":[{"contributorNames":[{"contributorName":"吉岡, 靖啓"}],"nameIdentifiers":[{},{}]},{"contributorNames":[{"contributorName":"石丸, 侑希"}],"nameIdentifiers":[{},{}]},{"contributorNames":[{"contributorName":"山室, 晶子"}],"nameIdentifiers":[{},{}]}]},"item_10007_description_11":{"attribute_name":"研究機関","attribute_value_mlt":[{"subitem_description":"摂南大学","subitem_description_type":"Other"}]},"item_10007_description_13":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"緑内障は、網膜神経節細胞の脱落によって失明に至る進行性の眼疾患である。緑内障の病態進行には、眼圧上昇が関与することが知られているが、眼圧を降下させても、緑内障の症状が進行する症例が数多く存在する。したがって、緑内障の網膜神経節細胞死を抑制する新たな治療薬の開発が求められている。本研究において、生理活性ペプチドであるアペリンが緑内障モデルマウスで生じる網膜神経節細胞死を抑制することを見出したことから、アペリンが新規緑内障治療薬となる可能性が示唆された。","subitem_description_type":"Abstract"}]},"item_10007_description_9":{"attribute_name":"研究課題番号","attribute_value_mlt":[{"subitem_description":"15K07983","subitem_description_type":"Other"}]},"item_10007_link_24":{"attribute_name":"リンク","attribute_value_mlt":[{"subitem_link_url":"https://kaken.nii.ac.jp/ja/report/KAKENHI-PROJECT-15K07983/15K07983seika/"}]},"item_access_right":{"attribute_name":"アクセス権","attribute_value_mlt":[{"subitem_access_right":"metadata only access","subitem_access_right_uri":"http://purl.org/coar/access_right/c_14cb"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"アペリン","subitem_subject_scheme":"Other"},{"subitem_subject":"APJ","subitem_subject_scheme":"Other"},{"subitem_subject":"緑内障","subitem_subject_scheme":"Other"},{"subitem_subject":"網膜神経節細胞","subitem_subject_scheme":"Other"},{"subitem_subject":"網膜神経節細胞死","subitem_subject_scheme":"Other"},{"subitem_subject":"神経保護","subitem_subject_scheme":"Other"},{"subitem_subject":"apelin","subitem_subject_scheme":"Other"},{"subitem_subject":"神経保護作用","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_researcher":{"attribute_name":"研究代表者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"前田, 定秋"}],"nameIdentifiers":[{},{}]}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"research report","resourceuri":"http://purl.org/coar/resource_type/c_18ws"}]},"item_title":"緑内障の新規治療薬としてのアペリンに関する研究―遺伝子改変動物を用いて―","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"緑内障の新規治療薬としてのアペリンに関する研究―遺伝子改変動物を用いて―"}]},"item_type_id":"10007","owner":"14","path":["197"],"pubdate":{"attribute_name":"公開日","attribute_value":"2019-07-04"},"publish_date":"2019-07-04","publish_status":"0","recid":"1205","relation_version_is_last":true,"title":["緑内障の新規治療薬としてのアペリンに関する研究―遺伝子改変動物を用いて―"],"weko_creator_id":"14","weko_shared_id":-1},"updated":"2023-06-19T11:56:33.296833+00:00"}